These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31385069)

  • 1. Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research.
    Vesterinen T; Salmenkivi K; Mustonen H; Kuopio T; Lappi-Blanco E; Paavonen T; Vainio P; Knuuttila A; Carpén O; Haglund C; Arola J
    Virchows Arch; 2020 Feb; 476(2):273-283. PubMed ID: 31385069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legacy samples in Finnish biobanks: social and legal issues related to the transfer of old sample collections into biobanks.
    Salokannel M; Tarkkala H; Snell K
    Hum Genet; 2019 Dec; 138(11-12):1287-1299. PubMed ID: 31620872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary carcinoid and related tumours.
    Hasleton PS; Bostanci G
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biobanks as a Central Part of the Finnish Growth and Genomic Strategies: How to Balance Privacy in an Innovation Ecosystem?
    Soini S
    J Law Med Ethics; 2016 Mar; 44(1):24-34. PubMed ID: 27256121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
    Cros J; Théou-Anton N; Gounant V; Nicolle R; Reyes C; Humez S; Hescot S; Thomas de Montpréville V; Guyétant S; Scoazec JY; Guyard A; de Mestier L; Brosseau S; Mordant P; Castier Y; Gentien D; Ruszniewski P; Zalcman G; Couvelard A; Cazes A
    Neuroendocrinology; 2021; 111(1-2):158-169. PubMed ID: 32015233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of MIB-1 in neuroendocrine tumours of the lung.
    Böhm J; Koch S; Gais P; Jütting U; Präuer HW; Höfler H
    J Pathol; 1996 Apr; 178(4):402-9. PubMed ID: 8691318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: a long-term single institution experience.
    Schrevens L; Vansteenkiste J; Deneffe G; De Leyn P; Verbeken E; Vandenberghe T; Demedts M
    Lung Cancer; 2004 Jan; 43(1):39-45. PubMed ID: 14698535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
    García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of biobanks on research outcomes in rare diseases: a systematic review.
    Garcia M; Downs J; Russell A; Wang W
    Orphanet J Rare Dis; 2018 Nov; 13(1):202. PubMed ID: 30419920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
    Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.
    Thomas CF; Tazelaar HD; Jett JR
    Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for potential undiagnosed Gaucher disease patients: Utilisation of the Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS) in conjunction with electronic health record data, tissue specimens, and small nucleotide polymorphism (SNP) genotype data available in Finnish biobanks.
    Pehrsson M; Heikkinen H; Wartiovaara-Kautto U; Mäntylahti S; Bäckström P; Lassenius MI; Uusi-Rauva K; Carpén O; Elomaa K
    Mol Genet Metab Rep; 2022 Dec; 33():100911. PubMed ID: 36092251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms.
    Ruffini E; Bongiovanni M; Cavallo A; Filosso PL; Giobbe R; Mancuso M; Molinatti M; Oliaro A
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):165-72. PubMed ID: 15200997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
    Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
    Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
    Pattenden HA; Leung M; Beddow E; Dusmet M; Nicholson AG; Shackcloth M; Mohamed S; Darr A; Naidu B; Iyer S; Marchbank A; Greenwood A; West D; Granato F; Kirk A; Ariyaratnam P; Loubani M; Lim E;
    Thorax; 2015 Apr; 70(4):379-81. PubMed ID: 25124060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
    Pukkala E; Andersen A; Berglund G; Gislefoss R; Gudnason V; Hallmans G; Jellum E; Jousilahti P; Knekt P; Koskela P; Kyyrönen PP; Lenner P; Luostarinen T; Löve A; Ogmundsdóttir H; Stattin P; Tenkanen L; Tryggvadóttir L; Virtamo J; Wadell G; Widell A; Lehtinen M; Dillner J
    Acta Oncol; 2007; 46(3):286-307. PubMed ID: 17450464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of pulmonary carcinoid tumours.
    Kennedy A
    Br J Dis Chest; 1979 Jan; 73(1):71-80. PubMed ID: 435380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined atypical carcinoid tumour and squamous cell carcinoma of the lung.
    Okazaki M; Sano Y; Soga Y; Katayama H; Sakao N; Shikatani Y; Yukumi S; Shigematsu H; Sugita A; Izutani H
    Intern Med; 2015; 54(11):1385-8. PubMed ID: 26027992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor.
    Vesterinen T; Mononen S; Salmenkivi K; Mustonen H; Räsänen J; Salo JA; Ilonen I; Knuuttila A; Haglund C; Arola J
    Acta Oncol; 2018 Aug; 57(8):1109-1116. PubMed ID: 29463166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.